Perioperative outcomes after aortic valve replacement via right anterior mini-thoracotomy with a rapid-deployment valve: a consecutive single-centre series
- 1Department of Cardiac Surgery, F. Ceynowa Specialist Hospital
- 2Department of Cardiac Surgery, Regional Specialist Hospital
- 3Department of Cardiac Surgery, Medical University of Silesia, Upper-Silesian Heart Center
Abstract
Background/objectives: Evidence for aortic valve replacement through right anterior thoracotomy (RAT) using the Edwards Intuity Elite rapid-deployment bioprosthesis remains limited, with only three dedicated single-centre series published to date. We aimed to describe perioperative safety, early haemodynamic performance, permanent pacemaker implantation for third-degree atrioventricular block, and new-onset postoperative atrial fibrillation in a consecutive single-centre cohort. Analyses of factors associated with these two rhythm endpoints were exploratory in nature.
Methods: This is a retrospective, single-arm, single-centre observational series with no sternotomy, ministernotomy or sutured-valve comparator. We analysed 70 consecutive patients undergoing isolated aortic valve replacement via RAT with the Edwards Intuity Elite bioprosthesis at a single institution. Percutaneous femoral arterial and venous cannulation was used in all cases. Outcomes were described for the whole cohort. For exploratory event-versus-no-event comparisons, Mann–Whitney U and Fisher's exact tests were applied to permanent pacemaker implantation and new-onset atrial fibrillation; Spearman rank correlation and Mann–Whitney U tests explored associations with operative times and discharge pressure gradients. Because only 6 pacemaker and 7 atrial fibrillation events occurred, statistical power was limited.
Results: Median age was 71.0 years and median EuroSCORE II was 1.0%. Median cross-clamp time was 61.0 min (IQR 54–75) and median cardiopulmonary bypass time was 103.5 min (IQR 84–115). In-hospital mortality was 1.4% (one death from femoral cannulation-site haemorrhage; 95% CI 0.0%–7.7%), and no strokes occurred. Permanent pacemaker implantation was required in 6 patients (8.6%; 95% CI 3.2–17.7%) and new-onset atrial fibrillation occurred in 7 (10.0%; 95% CI 4.1–19.5%); age was significantly associated with pacemaker implantation (median 75.5 vs. 71.0 years, p = 0.038), while other exploratory comparisons were not significant. No moderate or severe paravalvular leak was observed. Median postoperative mean gradient was 8.0 mmHg (IQR 6–10) and median length of stay was 6.0 days (IQR 6.0–7.0). Packed red blood cell transfusion was required in 63 patients (91.3% of 69 evaluable; 95% CI 82.0–96.7%), and reoperation for bleeding in 3 (4.3%; 95% CI 0.9–12.0%). Exploratory analyses detected no statistically significant association with atrial fibrillation or operative times. Implanted valve size correlated weakly and inversely with postoperative mean gradient (Spearman rho = −0.26, p = 0.032).
Conclusions: In this descriptive, low-risk, single-centre cohort, RAT with a rapid-deployment bioprosthesis was feasible and was followed by low discharge gradients. The observed pacemaker, atrial fibrillation, transfusion, bleeding and access-site event rates are real-world descriptive estimates and do not constitute comparative evidence of benefit over other approaches or prostheses. The small number of events precludes conclusions about predictors. Larger prospective multicentre studies with comparator groups and systematic echocardiographic follow-up are required.
Related
- Continuation of Clopidogrel in Total Knee Arthroplasty: Perioperative Bleeding and Cardiovascular Outcomes in a Consecutive Case Series
- vNOTES sentinel lymph node biopsy and hysterectomy for endometrial cancer staging: perioperative outcomes from a consecutive series
- Outcomes of rescue procedures in patients undergoing unsuccessful deployment of transcatheter mitral valve replacement.
- Isolated Robotic Mitral Valve Replacement Across Body Mass Index Categories: Early Perioperative Outcomes
- Surgery that looks like transcatheter aortic valve implantation: the transaxillary concept for minimally invasive aortic valve replacement in 1,848 consecutive patients
BibTeX
@article{jaworski2026perioperative,
title = {{Perioperative outcomes after aortic valve replacement via right anterior mini-thoracotomy with a rapid-deployment valve: a consecutive single-centre series}},
author = {Łukasz Jaworski and Krzysztof Jarmoszewicz and Marian Burysz and Sebastian Batkiewicz and Adam R. Kowalówka and Michał Kuteń},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
month = nov,
doi = {10.3389/fcvm.2026.1970611},
url = {https://www.frontiersin.org/articles/10.3389/fcvm.2026.1970611/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Perioperative outcomes after aortic valve replacement via right anterior mini-thoracotomy with a rapid-deployment valve: a consecutive single-centre series
AU - Łukasz Jaworski
AU - Krzysztof Jarmoszewicz
AU - Marian Burysz
AU - Sebastian Batkiewicz
AU - Adam R. Kowalówka
AU - Michał Kuteń
PY - 2026
DA - 2026/11/16
JO - Frontiers in Cardiovascular Medicine
DO - 10.3389/fcvm.2026.1970611
UR - https://www.frontiersin.org/articles/10.3389/fcvm.2026.1970611/full
AB - Background/objectives: Evidence for aortic valve replacement through right anterior thoracotomy (RAT) using the Edwards Intuity Elite rapid-deployment bioprosthesis remains limited, with only three dedicated single-centre series published to date. We aimed to describe perioperative safety, early haemodynamic performance, permanent pacemaker implantation for third-degree atrioventricular block, and new-onset postoperative atrial fibrillation in a consecutive single-centre cohort. Analyses of factors associated with these two rhythm endpoints were exploratory in nature. Methods: This is a retrospective, single-arm, single-centre observational series with no sternotomy, ministernotomy or sutured-valve comparator. We analysed 70 consecutive patients undergoing isolated aortic valve replacement via RAT with the Edwards Intuity Elite bioprosthesis at a single institution. Percutaneous femoral arterial and venous cannulation was used in all cases. Outcomes were described for the whole cohort. For exploratory event-versus-no-event comparisons, Mann–Whitney U and Fisher's exact tests were applied to permanent pacemaker implantation and new-onset atrial fibrillation; Spearman rank correlation and Mann–Whitney U tests explored associations with operative times and discharge pressure gradients. Because only 6 pacemaker and 7 atrial fibrillation events occurred, statistical power was limited. Results: Median age was 71.0 years and median EuroSCORE II was 1.0%. Median cross-clamp time was 61.0 min (IQR 54–75) and median cardiopulmonary bypass time was 103.5 min (IQR 84–115). In-hospital mortality was 1.4% (one death from femoral cannulation-site haemorrhage; 95% CI 0.0%–7.7%), and no strokes occurred. Permanent pacemaker implantation was required in 6 patients (8.6%; 95% CI 3.2–17.7%) and new-onset atrial fibrillation occurred in 7 (10.0%; 95% CI 4.1–19.5%); age was significantly associated with pacemaker implantation (median 75.5 vs. 71.0 years, p = 0.038), while other exploratory comparisons were not significant. No moderate or severe paravalvular leak was observed. Median postoperative mean gradient was 8.0 mmHg (IQR 6–10) and median length of stay was 6.0 days (IQR 6.0–7.0). Packed red blood cell transfusion was required in 63 patients (91.3% of 69 evaluable; 95% CI 82.0–96.7%), and reoperation for bleeding in 3 (4.3%; 95% CI 0.9–12.0%). Exploratory analyses detected no statistically significant association with atrial fibrillation or operative times. Implanted valve size correlated weakly and inversely with postoperative mean gradient (Spearman rho = −0.26, p = 0.032). Conclusions: In this descriptive, low-risk, single-centre cohort, RAT with a rapid-deployment bioprosthesis was feasible and was followed by low discharge gradients. The observed pacemaker, atrial fibrillation, transfusion, bleeding and access-site event rates are real-world descriptive estimates and do not constitute comparative evidence of benefit over other approaches or prostheses. The small number of events precludes conclusions about predictors. Larger prospective multicentre studies with comparator groups and systematic echocardiographic follow-up are required.
SN - 2297-055X
ER -